Literature DB >> 7791551

High resolution MR imaging of joint degeneration in the knee of the STR/ORT mouse.

J P Munasinghe1, J A Tyler, T A Carpenter, L D Hall.   

Abstract

MR imaging of the knee joints of the mouse at 2.35 T produces an in-plane resolution of 35 x 70 microns and a slice thickness of 600 microns from the sagittal and coronal planes, in less than 60 min. In normal, live DBA mice, which have no known pathology, the images clearly resolve many joint structures, such as the cruciate ligaments, menisci, and articulating surfaces of the femur and tibia. Gross pathological changes were identified first in excised knees from cadaver mice of the STR/ORT strain. Males of this strain spontaneously exhibit rapid joint degeneration with increasing age compared to females, in which much milder symptoms develop more slowly. Thickening of the patellar tendon, displacement of the patella, deformity, and sclerosis were clearly distinguishable in males compared with females older than 7 mo of age. The same degenerative features were evident in MR images of the knees of the live male but not female STR/ORT mice of this age, indicating that it would be possible to monitor longitudinally by MR imaging progressive development of joint changes in this osteoarthritic model.

Entities:  

Mesh:

Year:  1995        PMID: 7791551     DOI: 10.1016/0730-725x(94)00123-k

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  2 in total

Review 1.  New imaging tools for mouse models of osteoarthritis.

Authors:  S Drevet; B Favier; B Lardy; G Gavazzi; E Brun
Journal:  Geroscience       Date:  2022-02-07       Impact factor: 7.581

2.  CCN family member 2/connective tissue growth factor (CCN2/CTGF) has anti-aging effects that protect articular cartilage from age-related degenerative changes.

Authors:  Shinsuke Itoh; Takako Hattori; Nao Tomita; Eriko Aoyama; Yasutaka Yutani; Takashi Yamashiro; Masaharu Takigawa
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.